Intramedullary nails market to reach $1.32 billion by 2030

The Business Research Company says the global intramedullary nails market is set to grow from $0.94 billion in 2025 to $1.32 billion by 2030, driven by rising fracture rates, an aging population and wider use of orthopedic surgery. North America was the largest regional market in 2025, while the report highlights titanium alloy implants, minimally invasive procedures and improved access in emerging markets as key trends.

Why it matters: - Intramedullary nails are core devices in orthopedic trauma care for stabilizing long-bone fractures. - The market’s growth tracks with more fractures, more orthopedic procedures and broader access to surgical care. - Rising demand for fracture treatment can affect hospitals, ambulatory surgical centers and implant suppliers.

What happened: - The Business Research Company released an updated intramedullary nails market report on August 13, 2026. - The report projects market size will rise from $0.94 billion in 2025 to $1.01 billion in 2026. - The report forecasts the market will reach $1.32 billion by 2030. - North America was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the market report is available. - The full market report is also available.

The details: - Intramedullary nails are inserted into the medullary canal of long bones such as the femur, tibia and humerus. - The devices provide internal stabilization and keep fractured bones aligned for healing. - Historical growth was driven by road accidents and trauma cases, osteoporosis-related fractures, greater use of internal fixation techniques, expansion of hospital-based orthopedic surgeries and availability of stainless steel nails. - The report says future growth will be fueled by new nail designs and locking mechanisms, a larger elderly population, growth of ambulatory surgical centers, demand for titanium alloy implants and better access to orthopedic care in emerging markets. - Reported trends include more minimally invasive procedures, preference for anatomically designed nails, more titanium alloy use for biocompatibility, early mobilization, faster fracture healing and more trauma and orthopedic surgeries. - The report says the market also reflects a broader shift toward titanium alloy implants over stainless steel options. - A November 2024 National Library of Medicine report projected hip fracture cases in England, Wales and Northern Ireland will rise by about 107% by 2060.

Between the lines: - The market outlook suggests fracture care is being shaped by both demographic pressure and treatment innovation. - An aging population increases fracture risk, while better implant design and less invasive surgery can expand procedure volume. - Regional leadership in North America points to mature orthopedic infrastructure, but the report’s global scope signals room for faster growth in emerging markets. - The addition of TAM analysis, company scoring matrices, dashboards and hotspot graphics suggests the report is aimed at investors, suppliers and strategy teams as much as clinicians.

What's next: - The report expects continued demand through 2030 as fracture incidence rises and surgical capacity expands. - Adoption of titanium alloy nails and anatomically designed products is likely to remain a key competitive theme. - Growth in ambulatory surgical centers and emerging-market orthopedic access could shift more volume outside traditional hospital settings.

The bottom line: - Intramedullary nails remain a small but steadily expanding orthopedic market, with fracture prevalence and implant innovation doing most of the heavy lifting.